Today's Healthcare Pulse
Abridge teams with Eli Lilly and Nvidia to expand AI scribe platform
Abridge announced a strategic investment from Eli Lilly and a partnership with Nvidia to build a foundation model for clinical conversations. The collaboration aims to broaden Abridge’s AI‑scribe services across more health systems and integrate with payers. The company already supports over 300 health systems.
Also developing:
ChAnGe Project: Cardiopulmonary and Strength Analysis in Gender Transition
The ChAnGe project, led by Dr. Marco Vecchiato at the University Hospital of Padova, investigates cardiopulmonary function and muscular strength in transgender and gender‑diverse (TGD) individuals beginning gender‑affirming hormone therapy (GAHT). Since November 2024 the study has enrolled 16 TGD participants (10 men, 6 women) and 16 matched cisgender controls. Using exercise testing, metabolic profiling, and imaging, the team aims to capture physiological changes during medical transition. The research fills a critical gap in sports and exercise medicine, where TGD athletes are historically under‑studied.
Seed Medical Launches Psychiatric Services as HK Mental Health Rises
Hong Kong's mental health indicators have reached a critical red‑light level, with depression and anxiety scores climbing to 7.27 and 5.9, the highest since 2012. A recent survey shows 55 % of residents hesitate to seek professional help, while AI assistants...
Teva Advances Biosimilars Portfolio with Ponlimsi (Denosumab) FDA Approval and Dual Omalizumab Filing Acceptance
Teva Pharmaceutical received U.S. FDA approval for Ponlimsi, a biosimilar to Amgen’s Prolia (denosumab), covering all approved indications. The approval was granted after extensive analytical and clinical studies demonstrated comparable efficacy, safety, and immunogenicity to the reference product. In parallel,...
Orthodontic Treatment in Adulthood: What Really Changes?
Adult orthodontic treatment is increasingly common as modern technologies like clear aligners and ceramic braces make discreet, effective tooth movement possible well beyond adolescence. While teeth can shift at any age, successful outcomes hinge on healthy gums, adequate bone density,...
Where to Find the Best Invisalign Provider in Thornton
Choosing Invisalign is only half the journey; selecting a qualified provider determines treatment success. In Thornton, providers differ in experience, digital planning, communication, and post‑treatment support. The article outlines criteria such as case volume, use of intraoral scanners, clear timeline...
How Medical Technology Is Improving the Diagnosis of Binocular Vision Problems
Medical technology is transforming how clinicians diagnose binocular vision disorders, which often hide behind generic eye‑strain complaints. Traditional eye exams focus on static acuity, missing dynamic issues like accommodative and vergence dysfunction that cause headaches, dizziness, and reading difficulty. New...
Major Upgrade for Musgrove Park Hospital’s Nuclear Medicine Department
Musgrove Park Hospital in Somerset has reopened its Nuclear Medicine department after a comprehensive refurbishment and the installation of a state‑of‑the‑art SPECT/CT scanner. The new hybrid system delivers high‑resolution 3‑D images that combine functional and anatomical data, expanding the range...
Dr. Nishi Patel Discusses Modern Diagnostic Tools in Cardiology: From Echocardiograms to Cardiac MRIs
Dr. Nishi Patel outlines how echocardiography and cardiac MRI together shape modern cardiology in the United States. Echocardiograms serve as a low‑cost, widely available first‑line tool that provides real‑time functional data, while cardiac MRI delivers high‑resolution tissue characterization for complex...
Bioinspired Anti‐VEGF Peptide Nanoparticle with Immune Regulating and Corneal Epithelium Penetration Capability for Corneal Neovascularization Therapy
Researchers have engineered a bioinspired nanoparticle that co‑assembles an anti‑VEGF peptide with copper ions, adds a ROS‑scavenging moiety and a cell‑penetrating peptide, and achieves deep corneal delivery. The formulation extends ocular residence to roughly 70 minutes and reaches 300 µm in a...
Large‐Scale Ferroelectric Ceramic Wafer Achieved by Sintering Strategies for Sensitive High‐Temperature Self‐Powered X‐ray Detection
Researchers have fabricated a large‑scale ferroelectric ceramic wafer (PNN‑PZT) using solid‑state sintering, achieving record‑high sensitivity for self‑powered X‑ray detection. At 150 °C the detector reaches 248 µC Gy⁻¹ cm⁻² sensitivity and a detection limit of 6.76 nGy s⁻¹, surpassing commercial amorphous selenium devices. The material exhibits...
Healthcare’s Quiet Dependence on the “Possimpible”
Healthcare now leans on clinicians to deliver care that exceeds system capacity, filling gaps with unpaid, after‑hours tasks. This invisible labor fuels a chronic burnout crisis rooted in flawed system design rather than personal resilience. The article argues that without...
Association Between Pre-Operative Computed Tomography-Based Adipose Tissue Quantification and Post-Transplant Dyslipidemia in Renal Transplantation Recipients
A 2026 Frontiers in Nutrition study of 250 kidney‑transplant recipients found that pre‑operative visceral adipose tissue (VAT) measured by CT strongly predicts post‑transplant dyslipidemia. While BMI and other fat depots correlated with lipid abnormalities in univariate tests, multivariate models identified...
Low Vitamin D Status and 10-Year Dementia Risk in Sensory-Impaired Adults: A Propensity Score-Matched Cohort Study
Researchers analyzed over 158,000 adults aged 50+ with vision or hearing impairment using the TriNetX database. After propensity‑score matching, those with vitamin D deficiency (<20 ng/mL) faced a 55 % higher hazard of developing dementia over ten years compared with individuals with...
Application of an ACE Star Model–Based Evidence-Based Enteral Nutrition Management Protocol in Neurocritical Care Patients
Researchers applied the ACE Star evidence‑based model to create a standardized enteral nutrition protocol for neurocritical care patients in a Chinese tertiary ICU. Compared with a historical control, the protocol lowered feeding intolerance incidence from 70% to 31% and boosted...
L–Carnitine in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanisms and Therapeutic Potential
A new review in *Metabolism* outlines how L‑carnitine may counteract metabolic dysfunction‑associated steatotic liver disease (MASLD), which now afflicts roughly one‑third of the global population. The authors detail L‑carnitine’s role in boosting mitochondrial fatty‑acid oxidation, improving insulin sensitivity, and dampening...
'Something Wasn't Right': Wrong Sperm Given to UK Families by IVF Clinics in Northern Cyprus
A BBC investigation found that two British families who underwent IVF at Dogus IVF Centre in northern Cyprus received sperm from different, undisclosed donors, meaning their children are not biologically related. DNA testing confirmed neither child was conceived with the...
Home Halo Kicks Off Franchise Push With 10–15 Location Goal In First Year
Home Halo, a non‑medical home‑care provider, is entering franchising with a goal of opening 10‑15 locations in the next year and scaling to 20‑30 new sites annually thereafter. The company’s first franchisee controls twelve territories in eastern Massachusetts, using a...
Blackstone Closes Record $6.3B Life Sciences Fund: Institutional Capital Floods the Healthcare:
Blackstone announced the final close of its BXLS VI fund at a record $6.3 billion, making it the largest private‑capital vehicle devoted solely to life sciences. The fund was oversubscribed, ending roughly 40% larger than its predecessor, reflecting a surge of institutional...
Colon Cancer Screenings: When To Start
Colorectal cancer diagnoses are rising among adults under 50, prompting a shift in screening recommendations. The U.S. Preventive Services Task Force now advises average‑risk individuals to begin colonoscopy screening at age 45, down from 50. High‑risk patients—those with symptoms, family...
Low Sick Pay Is Making Britain Sicker
The UK’s statutory sick pay (SSP) remains at £118.75 a week (about $150), one of the lowest among advanced economies. Despite new legislation eliminating the three‑day unpaid waiting period and extending coverage to part‑time and low‑wage workers, the rate has...
:max_bytes(150000):strip_icc():format(jpeg)/paxil-withdrawal-symptoms-timeline-and-treatment-4769771_final-211352c6264747e2bb82f427757f8adf.png)
How Long Does Withdrawal From Paxil Last?
Paxil (paroxetine), a short‑acting SSRI, often triggers withdrawal symptoms within two to three days of dose reduction, with effects lasting up to six weeks or longer. Over half of antidepressant discontinuers report such symptoms, including nausea, dizziness, vivid dreams, anxiety,...
Diagnosed With Pancreatic Cancer: Now What?
Pancreatic cancer’s five‑year survival sits at just 13%, making early, expert care essential. The University of Michigan Rogel and Blondy Center emphasizes a multidisciplinary, high‑volume approach that includes surgeons, oncologists, dietitians, and palliative specialists. Patients are urged to seek centers...
Australian Government Rolls Out Free Medicare Mental Health Check‑In Service Nationwide
The Australian Government Department of Health has launched Medicare Mental Health Check‑In, a free online service that provides low‑intensity cognitive‑behavioural therapy tools and optional telehealth practitioner support for people with mild mental‑health challenges, starting 30 May 2026. The initiative expands...
Multidisciplinary Care Redefines Obesity Treatment, Says Malaysian Endocrinologist
Dr Kiran Nair of ParkCity Medical Centre highlighted a growing move toward multidisciplinary obesity care during World Obesity Day, arguing that weight loss alone is insufficient. She stressed that obesity is a chronic disease requiring coordinated medical, psychological and lifestyle...
India’s ICMR‑NIN Wraps Up World’s Largest Nutrition‑Biomarker Survey of 260,000 People
The Indian Council of Medical Research’s National Institute of Nutrition has finished a two‑year survey of 2.6 lakh individuals in 183 districts, linking diet, activity and blood biomarkers. The dataset, called DABS‑I, is the first of its kind in India and...
Tirzepatide Cuts Cardiorenal Events 14% vs Dulaglutide in Landmark Trial
A post‑hoc analysis of the SURPASS‑CVOT trial finds the dual GLP‑1/GIP agonist tirzepatide lowers a broad six‑component cardiorenal endpoint by 14% compared with the GLP‑1‑only drug dulaglutide. The result, presented at ACC 2026, could reshape how biohackers approach metabolic health...
Aurinia to Acquire Kezar for $6.96 per Share, Adding Immunoproteasome Asset
Aurinia Pharmaceuticals announced a definitive agreement to acquire Kezar Life Sciences for $6.955 in cash per share plus a contingent value right (CVR). The deal, slated to close in Q2 2026, gives Aurinia access to Kezar’s lead immunoproteasome inhibitor, zetomipzomib, and...
CNBC Documentary Spotlights Value‑Based Care as Engine for Brain Health and $6 Trillion GDP Boost
The Catalight Group and a coalition of health, economic and policy leaders premiered a CNBC documentary that frames value‑based care as the linchpin for brain health and a $6.2 trillion boost to global GDP. The film cites staggering productivity losses and...
Right Through the Skull
Researchers have unveiled a novel calvarial delivery platform that injects drug‑laden nanoparticles into the skull’s bone marrow. Immune cells within the diploic space capture the particles and migrate across skull‑meninges channels, ferrying the therapeutic cargo into the brain. In mouse...
Missile Cancer Study Finds Increased Rate of Two Cancers Based on More Data
The U.S. Air Force School of Aerospace Medicine’s Missile Community Cancer Study, now analyzing 148,078 cases from 1976‑2010, found statistically higher rates of testicular cancer and Hodgkin lymphoma among intercontinental ballistic missile (ICBM) personnel compared with other Airmen. Earlier phases...
AI-Powered Stroke Tool Linked to Improved Patient Outcomes in Large Clinical Trial
A large cluster‑randomized trial of more than 21,000 acute ischemic‑stroke patients across 77 Chinese hospitals tested an AI‑powered clinical decision support system (CDSS). The tool, which combines AI‑assisted imaging with guideline‑based treatment prompts, lowered the 3‑month composite vascular‑event rate from...
NIH Awards Top Scientific Teams for Innovations Linking Nutrition and Autoimmune Disease
The National Institutes of Health announced 15 winning teams in its Nutrition for Our Immune System Health (NOURISH) Autoimmunity Challenge, each receiving a $10,000 prize. The challenge solicited scalable, patient‑centered ideas that integrate diet, microbiome, and multi‑omics approaches to study...
Canada Unveils First Brain‑Heart‑Mental Health Guideline, Merging Cardiac and Neurologic Care
The University of Ottawa Heart Institute has published an 11‑point clinical practice guideline that integrates cardiovascular, neurological and mental‑health care. The C‑CHANGE/CMAJ guideline aims to replace siloed disease protocols with a patient‑centred, whole‑person approach, and it is already being rolled...
Doctors Warn Shallow Breathing Undermines Brain, Heart and Fuels Anxiety
Indian pulmonologists led by Dr. Sushil Gupta warn that chronic shallow breathing activates stress pathways, reduces focus and can cause cardiac arrhythmia. The warning comes as breath‑focused meditation apps see a surge in users seeking quick relief.
Study Shows 11‑Minute Sleep Boost Cuts Heart Risk by 10%
Researchers tracking 53,000 adults over eight years discovered that sleeping an extra 11 minutes each night, combined with modest increases in activity and vegetable intake, reduces the risk of heart attacks, stroke and heart failure by 10%. The findings give...
Immune Modulation Preps FDA Submission for Parkinson's Drug After 30‑Year Journey
Immune Modulation, Inc. announced it is finalizing pre‑IND toxicology and pharmacokinetic studies to file an FDA submission for hypoestoxide, a plant‑derived anti‑inflammatory candidate for Parkinson's disease. The move caps a 30‑year scientific trek that began with a rainforest compound identified...
United Therapeutics Shares Surge 12% on Positive TETON-1 Phase III Results
United Therapeutics reported that its TETON-1 Phase III trial met the primary endpoint, delivering a 130.1 mL improvement in forced vital capacity for idiopathic pulmonary fibrosis patients. The news lifted the stock more than 12% and set the company on a path...
Neurolief Secures $6 Million Investment After FDA Clears First At‑Home Brain Neuromodulation Therapy
Neurolief announced a $6 million milestone‑based investment from BrainsWay Ltd. following the FDA’s Premarket Approval of its Proliv™Rx at‑home brain neuromodulation system. The clearance marks the first prescription‑grade, home‑use device for adults whose depression has not responded to at least one...
Cheshire Deploys GoldCare to Strengthen Consumer Independence
Cheshire Independent Living Services in London, Ontario has rolled out GoldCare’s integrated healthcare software, including a consumer portal that offers real‑time access to personal attendant schedules. The portal empowers consumers and families with direct visibility, enhancing autonomy and reducing reliance...
Standardizing Health Data for Good Medicine and Connected Care
On March 31 2026 the Canadian Institute for Health Information released Version 2 of the Canadian Core Data for Interoperability (CACDI), a national standard that defines core patient, clinical, and provider data for seamless exchange. Co‑designed with patients, clinicians, Indigenous groups and digital‑health...
Hypercare Mobilizes Vascular Team During ‘Life and Limb’ Emergencies
Royal Victoria Regional Health Centre in Barrie completed a one‑year pilot of Hypercare for its Vascular Life and Limb emergency pathway. The platform replaced individual phone calls with a single‑tap, secure group alert, cutting hospital acceptance time from 15 minutes...
Medly Heart Monitoring Enters Commercialization Through Vitall
Medly, a smartphone‑based remote monitoring system for heart‑failure patients developed by Toronto’s University Health Network, is now being commercialized by Vitall Intelligence. The platform gathers weight, blood pressure and heart‑rate data via Bluetooth devices and uses an algorithm to flag...
Boner Bears Honey May Be Harmful Due to Hidden Drug Ingredients
The FDA has warned consumers to avoid Boner Bears Honey, a sexual‑enhancement honey sold online and in some stores, after laboratory tests revealed it contains undeclared sildenafil and tadalafil. The product was identified during an inspection of Pure Vitamins and...
Neurosurgeons at St. Michael’s Use Low-Field MRI to Assist Surgeries
Neurosurgeons at Toronto’s St. Michael’s Hospital have begun using the Hyperfine Swoop® low‑field MRI scanner inside the operating room to obtain immediate post‑resection images. The portable 0.064‑tesla device can be wheeled into the suite, allowing scans within minutes while surgeons...
University of Ottawa Launches New Applied AI Centre for Healthcare
The University of Ottawa has inaugurated the Ottawa Medical Artificial Intelligence Research Institute (OMARI), an applied‑research hub embedded in its Faculty of Medicine and linked to the city’s six hospitals. Led by AI expert Dr. Khaled El Emam, OMARI aims to...
Omeros Corp (OMER) Q4 2025 Earnings Call Transcript
Omeros Corp reported a Q3 2025 net loss of $30.9 million, but secured a transformative agreement with Novo Nordisk that could deliver up to $2.1 billion in upfront and milestone payments. The $240 million upfront cash will retire most short‑term debt and fund more...
Kairos Pharma Ltd (KAPA) Q4 2025 Earnings Call Transcript
Karyopharm Therapeutics posted Q4 2025 revenue of $34.1 million, an 11.8% year‑over‑year increase, while total 2025 revenue reached $146.1 million. Operating efficiency improved, with R&D and SG&A expenses down 17% and 16% respectively, yet the company recorded a GAAP net loss of...
Bioatla Inc (BCAB) Q4 2025 Earnings Call Transcript
BioAtla reported that it is in the final stages of a strategic partnership transaction expected to close by year‑end and disclosed FDA alignment on the phase‑3 design of its OSFI (OSV) trial for second‑line oropharyngeal squamous cell carcinoma. The trial...
Centessa Pharmaceuticals PLC (CNTA) Q4 2025 Earnings Call Transcript
Centene reported full‑year 2025 adjusted diluted EPS of $2.08, while Q4 showed a $(1.19) loss driven by a $389 million divestiture charge. Management guided 2026 adjusted EPS above $3, implying more than 40% year‑over‑year growth, anchored by Medicaid margin stabilization and...
Mink Therapeutics Inc (INKT) Q4 2025 Earnings Call Transcript
MiNK Therapeutics reported a cash position of $14.3 million, extended through 2026 after a $1.2 million raise, while posting a $2.9 million net loss for Q4. Clinical data showed AGENT‑797 combined with PD‑1 achieved a median overall survival of roughly 23 months in heavily...